Catamaran joins the CAR-NK fleet, raising $42m in first roundCatamaran Bio has weighed anchor with a $42 million first-round financing that will be used to pull its Share XCatamaran joins the CAR-NK fleet, raising $42m in first roundhttps://pharmaphorum.com/news/catamaran-joins-the-car-nk-fleet-raising-42m-in-first-round/
Bayer gains first Aliqopa approval in follicular lymphomaBayer has gained FDA accelerated approval for its follicular lymphoma drug Aliqopa (copanlisib), giving it entry to the Share XBayer gains first Aliqopa approval in follicular lymphomahttps://pharmaphorum.com/news/aliqopa-follicular-lymphoma/
